Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

Clinical trial NCT00135005 · COMPLETED

Trial details

NCT number: NCT00135005
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2005-08-01
Primary completion: 2006-11-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.